Drug Trial Radar · NCT06851910
Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia
Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Apr 21, 2025
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Hospital Universitari de BellvitgeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 28, 2025
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia
Conditions
- Trigeminal Neuralgia
Interventions
LacosamideDrug
Patients will be included if they are prescribed intravenous lacosamide for their trigeminal neuralgia exacerbation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain reliefTime frame: 2 hours post-infusion
- Adverse effectsTime frame: Through study completion, an average of 1 week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.